Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population
- PMID: 35733608
- PMCID: PMC9207282
- DOI: 10.1016/j.pmedr.2022.101853
Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population
Abstract
Introduction: Disparities in human papillomavirus (HPV) awareness and HPV vaccine uptake are likely exacerbated among racial/ethnic minority populations living in low-income areas. This study aims to determine the prevalence and correlates of HPV awareness and HPV vaccine uptake in an urban, low-income, racial/ethnic minority population.
Methods: Secondary data analyses were performed in 2021 using 380 participants aged 18-45 years from the 2019 National HIV Behavioral Surveillance for high-risk heterosexuals, which monitors HIV risk behaviors among individuals living in high-poverty, high HIV prevalence neighborhoods. Prevalence estimates and modified Poisson regression models were used to assess the relationship between HPV awareness and HPV vaccine uptake, and sociodemographic characteristics.
Results: Only 53% of participants had heard of HPV and 11.5% had received at least one dose of the HPV vaccine. Those who were female, non-Hispanic White or other, had public health insurance, lived above the federal poverty level, had experienced homelessness and incarceration, and had usual source of healthcare showed higher awareness of HPV while those who were younger, female, non-Hispanic White or other, recently incarcerated, had a usual source of healthcare, and had a healthcare encounter in the past year showed higher prevalence of HPV vaccine uptake.
Conclusions: Prevalence of HPV vaccination in this high-risk population was low and there was a lack of preventive care utilization. Further research is needed on how to effectively target these populations to not only increase vaccine uptake, but to mitigate barriers that contribute to low awareness and suboptimal vaccination uptake in high-risk heterosexual populations.
Keywords: HPV; HPV prevention; HPV vaccination; Health disparities; Human papillomavirus.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Centers for Disease Control and Prevention. Human Papillomavirus Fact Sheet. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services. https://www.cdc.gov/std/hpv/stdfact-hpv.htm. Published 2020. Accessed September 23, 2021.
-
- Centers for Disease Control and Prevention. HPV-Associated Cancers Rates by Race and Ethnicity. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services. https://www.cdc.gov/cancer/hpv/statistics/race.htm. Published 2020. Accessed October 6, 2020.
-
- Centers for Disease Control and Prevention. Cancers Associated with Human Papillomavirus, United States—2014–2018. USCS Data Brief, no. 26. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2021. https://www.cdc.gov/cancer/uscs/about/data-briefs/no26-hpv-assoc-cancers.... Published 2021. Accessed May 19, 2022.
-
- Centers for Disease Control and Prevention. HPV-Associated Cancer Diagnosis by Age. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2021. https://www.cdc.gov/cancer/hpv/statistics/age.htm. Published 2021. Accessed May 19, 2022.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
